Why did Church & Dwight (CHD) stock move recently?

On 8/21/2026, Church & Dwight moved -4.0% — Church & Dwight declined following the consumer packaged goods company's second-quarter earnings miss, part of a broader pullback in staples names on soft consumer demand. This is MarketChacha's decoded reason from filings and credible news; it is education, not buy/sell advice.

Is Church & Dwight (CHD) overvalued or fairly valued?

MarketChacha shows Church & Dwight's valuation in context — a trailing P/E of about 32.2, a forward P/E of about 25.8, a price-to-book of about 5.7 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

Does Church & Dwight's reported profit turn into cash?

Over 3 years, operating cash flow fully covered reported profit — earnings are backed by real cash. MarketChacha computes this cash-conversion check (1.64×) from reported figures — education, not a rating.

What is Church & Dwight's revenue?

Church & Dwight reported revenue of $6.2B for FY2025, with net profit of $736.8M, per official filings.

What is the share price of Church & Dwight (CHD)?

Church & Dwight last traded at $105.96 (+1.8% on the day), as of 10/20/2026 — a delayed quote shown for education, not investment advice.

Church & Dwight

CHD · NYSE · Consumer Staples · United States

Snapshot

TickerCHD

ExchangeNYSE

SectorConsumer Staples

IndustryHousehold & Personal Products

CountryUnited States

Employees5,550

HeadquartersEwing, United States

Websitewww.churchdwight.com

Filings tracked13

About Church & Dwight

Church & Dwight Co., Inc. develops, manufactures, and markets household, personal care, and specialty products. It operates in three segments: Consumer Domestic, Consumer International, and Specialty Products Division. The company offers baking soda, cat litters, laundry detergents, carpet deodorizers, and other baking soda-based products under the ARM & HAMMER brand; stain removers, cleaning solutions, laundry detergents, and bleach alternatives under the OXICLEAN brand; dry shampoos under the BATISTE brand; water flossers under the WATERPIK brand; oral care products under the THERABREATH brand; acne treatment products under the HERO brand; hand sanitizers under the TOUCHLAND brand; and condoms, lubricants, and vibrators under the TROJAN brand. It also provides home pregnancy and ovulation test kits under the FIRST RESPONSE brand; depilatories under the NAIR; oral analgesics under the ORAJEL brand; laundry detergents under the XTRA brand; and cold shortening and relief products under the ZICAM brand. In addition, the company's specialty products include animal and food productivity products, such as ARM & HAMMER baking soda as a feed additive to help dairy cow; BIO-CHLOR and FERMENTEN used to reduce health issues associated with calving, as well as needed protein; CELMANAX refined functional carbohydrate, a yeast-based prebiotic; and CERTILLUS a probiotics products used in the poultry, dairy, beef, and swine industries. Additionally, it offers sodium bicarbonate; and cleaning and deodorizing products. The company sells its consumer products through supermarkets, mass merchandisers, wholesale clubs, drugstores, convenience stores, home stores, dollar and other discount stores, pet and other specialty stores, websites and other e-commerce channels; and specialty products to industrial customers and livestock producers through distributors. Church & Dwight Co., Inc. was founded in 1846 and is headquartered in Ewing, New Jersey.

Who owns it

Insiders0.2%
Institutions94.8%
Public & other5.0%

1,473 institutional holders

Ownership breakdown from public market data.

Top holders

Blackrock Inc.9.46%
Vanguard Capital Management LLC6.54%
State Street Corporation5.92%
Vanguard Portfolio Management LLC5.55%
JPMORGAN CHASE & CO3.85%
Capital International Investors3.14%
Fundsmith LLP2.72%
Geode Capital Management, LLC2.69%

Largest institutional holders — last updated 6/30/2026.

Forensic scorecard

No major accounting red flags in the fundamentals we have — profit is backed by cash and returns look healthy.

Cash conversion1.64×

Over 3 years, operating cash flow fully covered reported profit — earnings are backed by real cash.

Net margin trend12.9% → 11.9%

Margin has held broadly steady over the period — stable profitability.

Return on equity18.4%

Latest ROE of 18.4% — capital is generating a healthy return.

Growth qualityrev 3% · PAT -1%

Profit growth is broadly tracking revenue growth — the earnings trend looks operational rather than one-off.

Computed by MarketChacha from reported figures (SEC XBRL). Education, not a rating or recommendation.

What's expected next

Next quarter

Rev $1.7B · EPS 1.03

Est. earnings growth +20.0%

Next fiscal year

Rev $6.5B · EPS 4.03

Est. earnings growth +6.9%

Analyst consensus estimates — not the company's own guidance.

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Financials at a glance

Source: SEC XBRL

Annual

Quarterly · last 8

Revenue (FY2025)

$6.2B

Net margin

11.9%

ROE

18.4%

Revenue CAGR (2y)

+2.8%

Profit CAGR (2y)

-1.3%

EPS (FY2025)

3.02

Net profit (FY2025)

$736.8M

Ask MarketChacha about CHD

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Why it moved

Aug 21, 2026
Church & Dwight declined following the consumer packaged goods company's second-quarter earnings miss, part of a broader pullback in staples names on soft consumer demand.
source 1 ↗· confidence: medium

Daily moves with the verified reason behind them. Education only — not investment advice.

Financials

Yearly

Period	Revenue	Net profit	EPS	Net margin	ROE
FY2025	$6.2B	$736.8M	3.02	11.9%	18.4%
FY2024	$6.1B	$585.3M	2.37	9.6%	13.4%
FY2023	$5.9B	$755.6M	3.05	12.9%	19.6%

Quarterly

Period	Revenue	Net profit	EPS	Net margin
2026Q2	$1.5B	$202.8M	0.85	13.3%
2026Q1	$1.5B	$216.3M	0.91	14.7%
2025Q3	$1.6B	$182.2M	0.75	11.5%
2025Q2	$1.5B	$191.0M	0.78	12.7%
2025Q1	$1.5B	$220.1M	0.89	15.0%
2024Q3	$1.5B	$-75.1M	-0.31	-5.0%
2024Q2	$1.5B	$243.5M	0.99	16.1%
2024Q1	$1.5B	$227.7M	0.93	15.1%
2023Q3	$1.5B	$177.5M	0.71	12.2%
2023Q2	$1.5B	$221.2M	0.89	15.2%
2023Q1	$1.4B	$203.2M	0.82	14.2%

Figures as reported, in reporting currency. Source: SEC XBRL.

Filings & announcements

2026

10-Q filing
SEC7/31/2026
8-K — Results of operations, Exhibits
SEC7/31/2026material
8-K — Shareholder vote results
SEC5/5/2026material
8-K — Results of operations, Exhibits
SEC5/1/2026material
10-Q filing
SEC5/1/2026
10-K filing
SEC2/12/2026
8-K — Results of operations, Exhibits
SEC1/30/2026material

2025

8-K — Reg FD disclosure, Other events, Exhibits
SEC12/9/2025material
8-K — Other events
SEC12/5/2025material
8-K — Results of operations, Exhibits
SEC10/31/2025material
10-Q filing
SEC10/31/2025
8-K — Results of operations, Exhibits
SEC8/1/2025material
10-Q filing
SEC8/1/2025

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed market data) are delayed and shown for reference only. Verify with the linked sources before acting.